Home › Immunocore And Lilly Announce Immunotherapy-Based Clinical Trial Collaboration In Melanoma
 

Keywords :   


Immunocore And Lilly Announce Immunotherapy-Based Clinical Trial Collaboration In Melanoma

2015-07-01 08:13:50| drugdiscoveryonline Home Page

Immunocore Limited and Eli Lilly and Company recently announced that they have entered into an immunotherapy-based clinical trial collaboration to explore the utility of Immunocore’s lead T-cell receptor based investigational therapeutic, IMCgp100, in combination with Lilly’s galunisertib (LY2157299) and merestinib (LY2801653) for the treatment of melanoma

Tags: trial clinical collaboration announce

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »